B. Foster

Internalization and activation of the rat liver insulin receptor kinase in vivo.

B. Posner, J. Burgess, J. Bergeron, 1989, The Journal of biological chemistry.

Development of a specific radioimmuno assay for E domain containing forms of insulin-like growth factor II.

W. R. Hudgins, J. Perdue, B. Foster, 1991, Advances in experimental medicine and biology.

Pharmacological characterization of CP-547,632, a novel vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for cancer therapy.

F. Rastinejad, W. Roberts, Eugenia Floyd, 2003, Cancer research.

Pervanadate [peroxide(s) of vanadate] mimics insulin action in rat adipocytes via activation of the insulin receptor tyrosine kinase.

I. G. Fantus, G. Deragon, B. Posner, 1989, Biochemistry.

Characterization of the insulin-like growth factor (IGF) receptor hi K562 erythroleukemia cells; evidence for a biological function for the type II IGF receptor

B. Posner, H. Guyda, B. Foster, 1988, Molecular and Cellular Endocrinology.

Discovery of novel isothiazole inhibitors of the TrkA kinase: structure-activity relationship, computer modeling, optimization, and identification of highly potent antagonists.

Matthew D. Wessel, Joel Morris, M. Wessel, 2006, Bioorganic & medicinal chemistry letters.